Economic evaluation of the anglo-Scandinavian cardiac outcomes trial (ASCOT)-blood pressure lowering arm (BPLA): A sub-study on incremental cost-effectiveness of amlodipine-based regimen vs. atenolol-based regimen in primary prevention among hypertensive patients with additional risk factors
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2007)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要